Report Detail

Request for Sample of this report

Pharma & Healthcare Global Oral GLP-1 Drug Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4734994
    • |
  • 24 August, 2026
    • |
  • Global
    • |
  • 63 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Oral GLP-1 Drug market size was valued at US$ 1552 million in 2025 and is forecast to a readjusted size of US$ 3193 million by 2032 with a CAGR of 11.7% during review period.
Oral GLP-1 drugs are tablet-based incretin therapies that activate the GLP-1 receptor to reduce appetite, improve satiety and support long-term weight reduction without injection. Compared with injectable GLP-1 products, oral drugs may expand access among needle-averse patients and primary-care users, but their commercial success depends on efficacy, gastrointestinal tolerability, dosing restrictions, reimbursement and large-scale API/formulation capacity. In 2025, Global oral GLP-1 drug sales were still in an early launch stage, with a gross margin range of 70%–85%. The chain covers peptide or small-molecule API synthesis, absorption-enhancing formulation technology, tablet manufacturing, clinical development, regulatory approval, payer access and chronic obesity-care distribution.
Growth is supported by the large untreated obesity population, patient preference for non-injectable therapy, payer interest in broader but potentially more manageable access models, and pharmaceutical companies’ efforts to extend GLP-1 treatment from specialist injection channels into primary care. Oral products also create a new segmentation layer in the obesity market because convenience, food restrictions, price and efficacy can be balanced differently from weekly injections.
This report is a detailed and comprehensive analysis for global Oral GLP-1 Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oral GLP-1 Drug market size and forecasts, in consumption value ($ Million), 2021-2032
Global Oral GLP-1 Drug market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Oral GLP-1 Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Oral GLP-1 Drug market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oral GLP-1 Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oral GLP-1 Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Eli Lilly and Company, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Oral GLP-1 Drug market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral Peptide GLP-1
Oral Small-Molecule GLP-1
Market segment by Indication Status
Approved for Obesity
Approved for Diabetes Only
Market segment by Channel
Retail Pharmacy
Direct-to-Consumer Pharmacy
Hospital
Market segment by Application
Obesity Care
Diabetes Care
Others
Market segment by players, this report covers
Novo Nordisk
Eli Lilly and Company
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oral GLP-1 Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oral GLP-1 Drug, with revenue, gross margin, and global market share of Oral GLP-1 Drug from 2021 to 2026.
Chapter 3, the Oral GLP-1 Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Oral GLP-1 Drug market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral GLP-1 Drug.
Chapter 13, to describe Oral GLP-1 Drug research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Oral GLP-1 Drug by Type
    • 1.3.1 Overview: Global Oral GLP-1 Drug Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Oral GLP-1 Drug Consumption Value Market Share by Type in 2025
    • 1.3.3 Oral Peptide GLP-1
    • 1.3.4 Oral Small-Molecule GLP-1
  • 1.4 Classification of Oral GLP-1 Drug by Indication Status
    • 1.4.1 Overview: Global Oral GLP-1 Drug Market Size by Indication Status: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Oral GLP-1 Drug Consumption Value Market Share by Indication Status in 2025
    • 1.4.3 Approved for Obesity
    • 1.4.4 Approved for Diabetes Only
  • 1.5 Classification of Oral GLP-1 Drug by Channel
    • 1.5.1 Overview: Global Oral GLP-1 Drug Market Size by Channel: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global Oral GLP-1 Drug Consumption Value Market Share by Channel in 2025
    • 1.5.3 Retail Pharmacy
    • 1.5.4 Direct-to-Consumer Pharmacy
    • 1.5.5 Hospital
  • 1.6 Global Oral GLP-1 Drug Market by Application
    • 1.6.1 Overview: Global Oral GLP-1 Drug Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Obesity Care
    • 1.6.3 Diabetes Care
    • 1.6.4 Others
  • 1.7 Global Oral GLP-1 Drug Market Size & Forecast
  • 1.8 Global Oral GLP-1 Drug Market Size and Forecast by Region
    • 1.8.1 Global Oral GLP-1 Drug Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global Oral GLP-1 Drug Market Size by Region, (2021-2032)
    • 1.8.3 North America Oral GLP-1 Drug Market Size and Prospect (2021-2032)
    • 1.8.4 Europe Oral GLP-1 Drug Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific Oral GLP-1 Drug Market Size and Prospect (2021-2032)
    • 1.8.6 South America Oral GLP-1 Drug Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa Oral GLP-1 Drug Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Novo Nordisk
    • 2.1.1 Novo Nordisk Details
    • 2.1.2 Novo Nordisk Major Business
    • 2.1.3 Novo Nordisk Oral GLP-1 Drug Product and Solutions
    • 2.1.4 Novo Nordisk Oral GLP-1 Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Novo Nordisk Recent Developments and Future Plans
  • 2.2 Eli Lilly and Company
    • 2.2.1 Eli Lilly and Company Details
    • 2.2.2 Eli Lilly and Company Major Business
    • 2.2.3 Eli Lilly and Company Oral GLP-1 Drug Product and Solutions
    • 2.2.4 Eli Lilly and Company Oral GLP-1 Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Eli Lilly and Company Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Oral GLP-1 Drug Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Oral GLP-1 Drug by Company Revenue
    • 3.2.2 Top 3 Oral GLP-1 Drug Players Market Share in 2025
    • 3.2.3 Top 6 Oral GLP-1 Drug Players Market Share in 2025
  • 3.3 Oral GLP-1 Drug Market: Overall Company Footprint Analysis
    • 3.3.1 Oral GLP-1 Drug Market: Region Footprint
    • 3.3.2 Oral GLP-1 Drug Market: Company Product Type Footprint
    • 3.3.3 Oral GLP-1 Drug Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Oral GLP-1 Drug Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Oral GLP-1 Drug Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Oral GLP-1 Drug Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Oral GLP-1 Drug Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Oral GLP-1 Drug Consumption Value by Type (2021-2032)
  • 6.2 North America Oral GLP-1 Drug Market Size by Application (2021-2032)
  • 6.3 North America Oral GLP-1 Drug Market Size by Country
    • 6.3.1 North America Oral GLP-1 Drug Consumption Value by Country (2021-2032)
    • 6.3.2 United States Oral GLP-1 Drug Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Oral GLP-1 Drug Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Oral GLP-1 Drug Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Oral GLP-1 Drug Consumption Value by Type (2021-2032)
  • 7.2 Europe Oral GLP-1 Drug Consumption Value by Application (2021-2032)
  • 7.3 Europe Oral GLP-1 Drug Market Size by Country
    • 7.3.1 Europe Oral GLP-1 Drug Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Oral GLP-1 Drug Market Size and Forecast (2021-2032)
    • 7.3.3 France Oral GLP-1 Drug Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Oral GLP-1 Drug Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Oral GLP-1 Drug Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Oral GLP-1 Drug Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Oral GLP-1 Drug Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Oral GLP-1 Drug Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Oral GLP-1 Drug Market Size by Region
    • 8.3.1 Asia-Pacific Oral GLP-1 Drug Consumption Value by Region (2021-2032)
    • 8.3.2 China Oral GLP-1 Drug Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Oral GLP-1 Drug Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Oral GLP-1 Drug Market Size and Forecast (2021-2032)
    • 8.3.5 India Oral GLP-1 Drug Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Oral GLP-1 Drug Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Oral GLP-1 Drug Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Oral GLP-1 Drug Consumption Value by Type (2021-2032)
  • 9.2 South America Oral GLP-1 Drug Consumption Value by Application (2021-2032)
  • 9.3 South America Oral GLP-1 Drug Market Size by Country
    • 9.3.1 South America Oral GLP-1 Drug Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Oral GLP-1 Drug Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Oral GLP-1 Drug Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Oral GLP-1 Drug Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Oral GLP-1 Drug Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Oral GLP-1 Drug Market Size by Country
    • 10.3.1 Middle East & Africa Oral GLP-1 Drug Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Oral GLP-1 Drug Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Oral GLP-1 Drug Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Oral GLP-1 Drug Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Oral GLP-1 Drug Market Drivers
  • 11.2 Oral GLP-1 Drug Market Restraints
  • 11.3 Oral GLP-1 Drug Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Oral GLP-1 Drug Industry Chain
  • 12.2 Oral GLP-1 Drug Upstream Analysis
  • 12.3 Oral GLP-1 Drug Midstream Analysis
  • 12.4 Oral GLP-1 Drug Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Oral GLP-1 Drug. Industry analysis & Market Report on Oral GLP-1 Drug is a syndicated market report, published as Global Oral GLP-1 Drug Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Oral GLP-1 Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo